How Gilead Bought Off the NIH’s Support of Remdesivir
Executive Summary Gilead Science received a monopoly and approval on a useless and deadly called Remdesivir. How the NIH turned its back on the public interest. Introduction Remdesivir is a drug that is $3120 per dose (for a 5-day treatment) that is ineffective against covid, and the FDA has approved it. This article covers how…